Skip to main content
. Author manuscript; available in PMC: 2021 Feb 17.
Published in final edited form as: Nature. 2020 Jul 29;587(7835):657–662. doi: 10.1038/s41586-020-2601-5

Extended Data Table 3. Binding kinetics of PLpro to K48-Ub2 or ISG15.

kon ± S.E.Ma koff S.E.Ma kd ± S.E.Ma R2b
(102M-1s-1) (10-1 s-1) (μM)
CoV2 Triazole linked K48-Ub2 158 ±8.00 4.30 ±0.11 27.28 ±1.55 0.99
PLpro HumanISG15 1530 ±52.4 2.15 ±0.06 1.41 ±0.06 0.99
MouseISG15 122 ±4.48 0.20 ± 0.02 1.64 ±0.17 0.97
SARS PLpro Triazole linked K48-Ub2 820 ±32.1 0.81 ±0.02 0.99 ± 0.04 0.98
HumanISG15 88.8 ±14.5 0.76 ± 0.06 8.60 ±1.56 0.98
MouseISG15 24.7 ± 0.75 0.23 ± 0.01 9.34 ±0.41 0.98

Binding kinetic parameters for SCoV-PLpro, SCoV2-PLpro to triazole-linked K48-Ub2, humanISG15 or mouseISG15 are presented. Values are presented as mean ± s.e.m. (n = 3, independent experiments).

a

s.e.m.

b

R 2, goodness of the curve fit between experimental data and mathematical 1:1 binding curve